Modules
Whitmore Pathology Associates, Inc.
Customer 5440
- Account Classification
- Unknown
- Classification Confidence
- Medium
- Sites
- HQ
- Assigned Reps
- Raymond Sutter
- Website
- —
- Active Opportunity Count
- 1
- Published Count
- 0
- Revenue Base
- 0
- Known GPBase
- 0
- Analyzer Platforms
- Beckman Access / DxI
- Product Groups
- —
- Recommended Contact
- Contact Enrichment Required
- Backup Contact
- —
- Last Meaningful Activity
- —
- Customer Memory
- Verified transaction fact: platform/product group signal is Beckman Access / DxI. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | Customer 5440
Opportunities (2)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | OPP-50cedd9a3e3f93e3517182b814a35224adeec1c0cdd938886c898a875c531157 | SER-fc3b62d3d430662f48d3cd5ac8b6e63a72685cd4482b93bd6e9315b8cf9f57a6 | Needs Validation | **** | **** | **** | Whitmore Pathology Associates, Inc. | 5440 | HQ | Brooklyn | NY | Northeast | Unknown | Medium | Beckman Access / DxI | — | — | — | — | — | Analyzer Platform Purchasing Loss; 3 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1481.60; 318 days beyond expected account order date. | 377.32 | 754.63 | 1131.95 | 280.19 | 560.38 | 840.57 | 66.14 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | Customer 5440 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | OPP-50cedd9a3e3f93e3517182b814a35224adeec1c0cdd938886c898a875c531157 | SER-fc3b62d3d430662f48d3cd5ac8b6e63a72685cd4482b93bd6e9315b8cf9f57a6 | — | **** | — | — | Whitmore Pathology Associates, Inc. | 5440 | HQ | — | NY | — | — | — | Beckman Access / DxI | — | — | — | — | — | Analyzer Platform Purchasing Loss; 3 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1481.60; 318 days beyond expected account order date. | — | 754.63 | — | — | 560.38 | — | 66.14 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | Customer 5440 |